Douglas Dougan

---

Doug is an accomplished structural biologist with 24 years of experience in X-ray crystallography, protein modeling, data collection, structure refinement, and target selection.

As structural biology lead at Syrrx and Takeda Pharmaceuticals, he provided strategic leadership across gene-to-structure and drug discovery initiatives, contributing to more than 50 programs and advancing over 10 candidate nominations, including 2 clinical candidates. His expertise spans multiple target classes and therapeutic areas.